Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.

Azuma, E

Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Sep 1989 - 1524-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0022-1767


Animals
Bone Marrow--immunology
Bone Marrow Transplantation
Clone Cells--immunology
Cytotoxicity, Immunologic
Female
Graft Rejection
Graft Survival
Graft vs Host Disease--prevention & control
Immunity, Innate--radiation effects
Immunization, Passive
Interleukin-1--pharmacology
Isoantigens--genetics
Killer Cells, Natural--classification
Lymphocyte Activation--radiation effects
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Inbred C57BL
Phenotype
Radiation Chimera
Recombinant Proteins--pharmacology